Pharmaceutical composition for preventing or treating immune dysregulation-related diseases comprising oxidized immunoglobulin as active ingredient
AssigneeAjou University Industry-Academic Cooperation Foundation
InventorDong Ho Nahm
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical composition for preventing or treating immune dysregulation-related diseases, including oxidized immunoglobulin as an active ingredient and a preventive or therapeutic method using same, a pharmaceutical composition for treating allergic diseases, chronic inflammatory diseases, autoimmune diseases or malignant tumor diseases, including as an active ingredient oxidized immunoglobulin obtained through artificially induced oxidation; and a novel immunomodulatory therapy which, by administering the composition to patients with the diseases, is differentiated from existing immunoglobulin therapeutic agents and more effective.
Claims28
A method of preventing or treating diseases associated with immune dysregulation in a subject, comprising:
- administering a pharmaceutical composition comprising oxidized immunoglobulin as an active ingredient to the subject.
A method of preventing or treating diseases associated with immune dysregulation, the method comprising:
- isolating immunoglobulin from blood of a mammal itself or isolating immunoglobulin from blood of another mammal (step 1);
- mixing and reacting the isolated immunoglobulin with an oxidant to prepare oxidized immunoglobulin (step 2);
- and
- administering the oxidized immunoglobulin to an individual suffering from a disease associated with immune dysregulation (step 3).
A method of preparing a pharmaceutical composition for preventing or treating diseases associated with immune dysregulation, the method comprising:
- isolating immunoglobulin from blood of a mammal itself or isolating immunoglobulin from blood of another mammal (step 1);
- and
- mixing and reacting the isolated immunoglobulin with an oxidant to prepare oxidized immunoglobulins (step 2).
Dependencies are inferred from the claim text.